STIMEL-03

Motion Informatics. Ltd

Migdal Haemek, Israel

Motion Informatics is at the forefront of revolutionizing chronic disease management, leveraging its extensive expertise in neuroscience, non-invasive neuromodulation, and neuromuscular medicine, enriched by cutting-edge technologies. The company's flagship technology, BioRhythmIQ, integrates artificial intelligence (AI), augmented reality (AR), and advanced biofeedback with Functional Electrical Stimulation (FES) and Neuromuscular Electrical Stimulation (NMES) to deliver personalized therapies that significantly enhance patient outcomes. Our proprietary BioRhythmIQ technology utilizes the power of wearable devices to offer non-invasive, tailored treatment solutions that dramatically improve the quality of life for patients. Our areas of focus include managing neurodegenerative and neuromuscular diseases, facilitating post-stroke rehabilitation, and treating conditions like Parkinson's disease, essential tremors, epilepsy, and various movement disorders. By combining pioneering neuroscience with the latest technology, Motion Informatics sets new standards of care for these chronic conditions. The Stimel-03, a prime example of our innovation, is currently available in the markets of the USA, India, and Asia. This device embodies our commitment to integrating comprehensive treatment solutions into everyday patient care, making advanced medical technologies accessible and effective. Under the guidance of a seasoned leadership team with profound global experience, Motion Informatics excels in both strategic vision and operational excellence. With a strong global footprint, our unwavering commitment to innovation and patient-centric approaches solidly positions us as a leader in the medical technology industry, dedicated to advancing the field of neuromodulation therapy.